Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALS

NCT04165850 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis
ALS

Interventions

DRUG: Fixed dose combination Ciprofloxacin/Celecoxib

Sponsor

NeuroSense Therapeutics Ltd.